Eye Health News and Research

Latest Eye Health News and Research

Special orchestra boosts mood and confidence in patients with dementia

A special orchestra for people with dementia has helped boost their confidence and mood, according to a new research project.

11 Nov 2015

Lowering blood pressure below currently recommended targets reduces risk of stroke, heart attack

Using intensive treatment to lower blood pressure below currently recommended targets significantly reduces rates of major cardiovascular events like stroke and heart attack among a wide range of high-risk patients, according to a large meta-analysis involving almost 45000 individuals, published in The Lancet.

11 Nov 2015

Cotellic (cobimetinib) approved to be used in combination with vemurafenib for melanoma treatment

The U.S. Food and Drug Administration today approved Cotellic (cobimetinib) to be used in combination with vemurafenib to treat advanced melanoma that has spread to other parts of the body or can't be removed by surgery, and that has a certain type of abnormal gene (BRAF V600E or V600K mutation).

10 Nov 2015

Purple Button mobile app helps HMC achieve overall goal of improving patient safety, quality

CRG Medical officially announced today the implementation of the ONC for IT award winning Purple Button mobile patient safety application at HMC. The Purple Button, powered by CRG Medical, supports the KB Core High Reliability Patient Safety Evaluation System and has been instrumental in assisting HMC toward their overall goal of improving patient safety, quality and satisfaction.

10 Nov 2015

New method may extend use of noninvasive prenatal testing to detect chromosomal abnormalities

Researchers at the University of California, San Diego School of Medicine developed a method to expand the types of chromosomal abnormalities that noninvasive prenatal testing (NIPT) can detect. The study, published November 9 by Proceedings of the National Academy of Sciences, uses a semiconductor sequencing platform to identify small chromosomal deletions or duplications, such as occur in Cri du Chat Syndrome and DiGeorge Syndrome, with a simple blood test from the expectant mother.

10 Nov 2015

L-DOPA drug may delay or prevent age-related macular degeneration

A drug already used safely to treat Parkinson's disease, restless leg syndrome and other movement disorders also could delay or prevent the most common cause of blindness affecting more than 9 million older Americans - age-related macular degeneration (AMD).

10 Nov 2015

Drug used to treat Parkinson's and related diseases may delay or prevent macular degeneration

In a major scientific breakthrough, a drug used to treat Parkinson's and related diseases may be able to delay or prevent macular degeneration, the most common form of blindness among older Americans.

10 Nov 2015

Astellas enters into definitive agreement to acquire Ocata

Astellas Pharma Inc. and Ocata Therapeutics, Inc., a biotechnology company focused on the research and development of new therapies in the field of regenerative medicine, primarily cell therapy addressing unmet medical needs in ophthalmology patients, announced today that they have entered into a definitive agreement.

10 Nov 2015

Nightstar announces $35 million Series B financing round

NightstaRx Ltd, a biopharmaceutical company specialising in developing gene therapies for inherited retinal dystrophies, announces a $35 million Series B financing round. The round was led by New Enterprise Associates, one of the world's leading venture capital firms.

9 Nov 2015

Dusseldorf will be the meeting point for MEDICA and COMPAMED this week

In the coming week, from 16 to 19 November 2015, Düsseldorf will again become the central meeting point of the international health business. Then, for the first time on the new set of dates from Monday to Thursday (previously: Wednesday to Saturday), the world’s largest medical trade fair, MEDICA, and the international leading supplier specialist trade fair, COMPAMED taking place at the same time, are going to start.

9 Nov 2015

Excelitas Technologies® Corp. and Quorum Technologies Present Microscopy Systems for Optogenetics Webinar

Excelitas Technologies® Corp. and Quorum Technologies will present a webinar entitled “How Can I Build a Microscopy System for Optogenetics?” led by featured speakers Kavita Aswani, Ph.D., senior applications scientist for the Life Sciences products at Excelitas Technologies, and Ryan Geil, M.Sc., service manager at Quorum Technologies Inc. The session will be moderated by Photonics Media and takes place on Thursday, November 12 at 1:00 pm (EST).

9 Nov 2015

Touch Surgery Officially The Largest Worldwide Community Of Surgeons Practicing Surgery Virtually

Digital Surgical Simulator Touch Surgery Collaborates with Experts Surgeons at International Institutions (Stanford, Yale, Dartmouth, Vanderbilt, Imperial College London, Singapore National Eye Center & Others) to Create Simulations of Surgical Best Practices.

6 Nov 2015

Better visualization in complex reconstructive surgery with ZEISS Opmi Pentero 800 surgical microscope

The capabilities of the OPMI® PENTERO® 800 surgical microscopes from ZEISS for reconstructive surgery have been enhanced by the introduction of the INFRARED 800 module.

From Carl Zeiss Microscopy GmbH 6 Nov 2015

UCSF scientists identify eye drop chemical that may reverse cataracts

A chemical that could potentially be used in eye drops to reverse cataracts, the leading cause of blindness, has been identified by a team of scientists from UC San Francisco (UCSF), the University of Michigan (U-M), and Washington University in St. Louis (WUSTL).

6 Nov 2015

Boxing more dangerous than mixed martial arts, shows study

Mixed martial arts has a reputation for being one of the most brutal and bloody of all contact sports, but the reality is boxing poses a greater risk of serious injury, according to new research from the University of Alberta.

6 Nov 2015

Men exposed to domestic violence more worried about not being believed

Men who receive help from crisis centres are mostly satisfied with the help they get. But they fear that nobody will believe that they've been abused by a woman.

6 Nov 2015

RXi Pharmaceuticals begins Phase 1/2 clinical trial in ophthalmology

RXi Pharmaceuticals Corporation a biotechnology company focused on discovering and developing innovative therapies primarily in the areas of dermatology and ophthalmology today announced the initiation of a Phase 1/2 clinical trial in ophthalmology. The clinical study RXI-109-1501 will evaluate the safety and clinical activity of RXI-109 to prevent the progression of retinal scarring, a harmful component of numerous retinal diseases.

5 Nov 2015

UConn-led researchers develop simple technique for diagnosis and monitoring of sickle cell disease

A team of UConn biomedical engineers, working with colleagues from Yale, MIT, and Harvard, has developed a simple, inexpensive, and quick technique for the diagnosis and monitoring of sickle cell disease that can be used in regions where advanced medical technology and training are scarce.

5 Nov 2015

Study suggests need for specific treatment options for adolescents with onset type 2 diabetes

New results from the Treatment Options for Type 2 Diabetes in Youth study (TODAY) examined predictors of the outcomes in youth with onset type 2 diabetes (T2D) based on early characteristics at diagnosis, and suggests the need for specific criteria for adolescents that are different from those in adults.

5 Nov 2015

JEDI T-cells provide unique technology to study, visualize immune responses and immunotherapies

When it comes to fending off disease and helping prevent people from falling ill, the body's immune system -- armed with T-cells that help eliminate cancer cells, virus-infected cells and more -- is second to none. But exactly how the immune system works remains, in many ways, a mystery, as there are numerous cell types whose functions and interactions with our immune systems have not been well understood.

5 Nov 2015

Eye Health News and Research

Latest Eye Health News and Research

Special orchestra boosts mood and confidence in patients with dementia

Lowering blood pressure below currently recommended targets reduces risk of stroke, heart attack

Cotellic (cobimetinib) approved to be used in combination with vemurafenib for melanoma treatment

Purple Button mobile app helps HMC achieve overall goal of improving patient safety, quality

New method may extend use of noninvasive prenatal testing to detect chromosomal abnormalities

L-DOPA drug may delay or prevent age-related macular degeneration

Drug used to treat Parkinson's and related diseases may delay or prevent macular degeneration

Astellas enters into definitive agreement to acquire Ocata

Nightstar announces $35 million Series B financing round

Dusseldorf will be the meeting point for MEDICA and COMPAMED this week

Excelitas Technologies® Corp. and Quorum Technologies Present Microscopy Systems for Optogenetics Webinar

Touch Surgery Officially The Largest Worldwide Community Of Surgeons Practicing Surgery Virtually

Better visualization in complex reconstructive surgery with ZEISS Opmi Pentero 800 surgical microscope

UCSF scientists identify eye drop chemical that may reverse cataracts

Boxing more dangerous than mixed martial arts, shows study

Men exposed to domestic violence more worried about not being believed

RXi Pharmaceuticals begins Phase 1/2 clinical trial in ophthalmology

UConn-led researchers develop simple technique for diagnosis and monitoring of sickle cell disease

Study suggests need for specific treatment options for adolescents with onset type 2 diabetes

JEDI T-cells provide unique technology to study, visualize immune responses and immunotherapies

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Eye Health News and Research

Latest Eye Health News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in